Prof. Zelig Eshhar exemplifies ICA's motto - Today's research is tomorrow's cure


Miri Ziv, ICA Director General, lauds the news item that has been published concerning the fact that an experimental treatment has led to the recovery of 94% of patients who have participated in a clinical trial.


Beyond the fact that this is encouraging information and that it provides hope for patients, their families and the general population, this news reinforces the importance of investing resources in research - and this is exactly what the ICA has been doing throughout the years.


The above treatment method has been developed based on the scientific discoveries of Prof. Zelig Eshhar of the Weizmann Institute, and Israel Prize recipient, who, at the outset of his career, received ICA research grants, and this year even participated in the opening ceremony of the 'Door Knock' Fundraising Campaign held at the Presidential Residence.


Prof. Zelig Eshhar and Yuval Aviv


Prof. Eshhar and Yuval Aviv (a young teen who recovered from cancer thanks to the development of Prof. Eshhar's vaccine) at this year's 'Door Knock' Fundraising Campaign opening ceremony held at the Presidential Residence in the presence of the President of the State of Israel, H.E. Reuven Rivlin and his wife Nehama.


That being said, the ICA's motto: 'today's research is tomorrow's cure', is actually being put into practice on the ground.